Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023.
Kissling E, Maurel M, Emborg HD, Whitaker H, McMenamin J, Howard J, Trebbien R, Watson C, Findlay B, Pozo F, Bolt Botnen A, Harvey C, Rose A; European IVE group; Members of the European IVE group.
Kissling E, et al.
Euro Surveill. 2023 May;28(21):2300116. doi: 10.2807/1560-7917.ES.2023.28.21.2300116.
Euro Surveill. 2023.
PMID: 37227299
Free PMC article.